Abstract:RationaleAntipsychotic drugs (APDs) were widely used in treating schizophrenia. Some APDs were reported to have neuroprotective effects against neurotoxicants in the cell level.ObjectivesThus, one typical APD (haloperidol) and three atypical APDs (paliperidone, olanzapine, and risperidone) were tested whether they provide neuroprotection against stressor-induced cell death of SH-SY5Y.MethodsHydrogen peroxide, N-methyl-4-phenylpyridinium ion, and β-amyloid peptide were used to treat cells with or without preconditioning by APDs; cell survival and indicators of oxidative stress were measured, respectively.ResultsPaliperidone has the lowest baseline cytotoxicity compared with other APDs at 24 h; in addition, the paliperidone group showed a better survival than the other APD groups (P < 0.05). In stressor challenging, with a fixed concentration of stressors, olanzapine provided the best neuroprotection at 100 μM against Aβ25-35 and MPP+ (P < 0.05). In contrast, paliperidone works finely at low concentrations (10 and 50 μM) against Aβ25-35 and MPP+ and solely protected SH-SY5Y from hydrogen peroxide. At 100 μM, paliperidone completely diminished cell reduction induced by different stressors, regardless of their dosages. Paliperidone was demonstrated with a higher oxidative stress-scavenging properties than other APDs in several aspects, such as generated bulk glutathione, low HNE, and protein carbonyl productions. Contradictorily, olanzapine, at 24 h, also enhanced HNE and protein carbonyl productions, which may underlie its induced cytotoxicity.ConclusionsDifferent APDs exhibit variations against different stressors. Paliperidone might be useful not only in alleviating oxidative stress induced by Aβ25-35 and MPP+ but also in providing neuroprotection against hydrogen peroxide.

Paliperidone Increases Spontaneous and Evoked Firing of Mesocortical Dopaminergic Neurons by Activating a Hyperpolarization-Activated Inward Current

Paliperidone Protects SK-N-SH Cells Against Glutamate Toxicity Via Akt1/GSK3β Signaling Pathway.

Paliperidone Alleviates MK-801-induced Damage to Prefrontal Cortical Neurons Via the PP2A/PTEN Pathway.

Paliperidone Protects SH-SY5Y Cells Against MK-801-Induced Neuronal Damage Through Inhibition of Ca 2+ Influx and Regulation of SIRT1/miR-134 Signal Pathway

Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia

Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia A Randomized, Double-Blind, Multicenter Study

Paliperidone Protects Prefrontal Cortical Neurons from Damages Caused by MK-801 Via Akt1/GSK3β Signaling Pathway

Paliperidone to Treat Psychotic Disorders

Activation of Presynaptic D1 Dopamine Receptors by Dopamine Increases the Frequency of Spontaneous Excitatory Postsynaptic Currents Through Protein Kinase A and Protein Kinase C in Pyramidal Cells of Rat Prelimbic Cortex

Characterization of Dopamine-Induced Depolarization of Prefrontal Cortical Neurons.

Contribution of Dopamine D1/5 Receptor Modulation of Post-Spike/Burst Afterhyperpolarization to Enhance Neuronal Excitability of Layer V Pyramidal Neurons in Prepubertal Rat Prefrontal Cortex

Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide25-35, N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death

Improvement of Mitochondrial Function by Paliperidone Attenuates Quinolinic Acid-Induced Behavioural and Neurochemical Alterations in Rats: Implications in Huntington’s Disease

Chronic haloperidol increases voltage-gated Na+ currents in mouse cortical neurons

Dopaminergic inhibition of the inwardly rectifying potassium current in direct pathway medium spiny neurons in normal and parkinsonian striatum

Effects of paliperidone on MK-801-induced hyperactivity and disruption prepulse inhibition in rats

Advance in research of paliperidone, a new antipsychotic

P.731 Dopaminergic Modulation of Frontostriatal Networks in Disorders of Addiction and Compulsion

Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets

Dopaminergic Modulation of Axonal Potassium Channels and Action Potential Waveform in Pyramidal Neurons of Prefrontal Cortex

Cyproheptadine Regulates Pyramidal Neuron Excitability in Mouse Medial Prefrontal Cortex